A number of new molecular entities (NMEs) selected for full-scale development based on their safety and pharmacological data suffer from undesirable physicochemical and biopharmaceutical properties, which lead to poor pharmacokinetics and distribution after in vivo administration. An optimization of
โฆ LIBER โฆ
Pharmaceutical New Product Development: The Increasing Role of In-Licensing
โ Scribed by Edwards, Nancy V.
- Book ID
- 123013098
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 116 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1932-2275
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Role of nanotechnology in pharmaceutical
โ
Harikrishna Devalapally; Ananthsrinivas Chakilam; Mansoor M. Amiji
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 292 KB
Innovation risks of outsourcing in pharm
โ
M. Lowman; P. Trott; A. Hoecht; Z. Sellam
๐
Article
๐
2012
๐
Elsevier Science
๐
English
โ 223 KB
The Role of Globalization in New Product
โ
Ozer, M.; Cebeci, U.
๐
Article
๐
2010
๐
IEEE
๐
English
โ 292 KB
New product development in the pharmaceu
โ
D. Jane Bower
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 842 KB
A Comprehensive Guide to Toxicology in P
โ
Kirby, Neil
๐
Article
๐
2013
๐
Elsevier
๐
English
โ 358 KB
*A Comprehensive Guide to Toxicology in Preclinical Drug Development* is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case
The Role of the User in Successful New P
โ
Stephen T. Parkinson
๐
Article
๐
1982
๐
John Wiley and Sons
๐
English
โ 687 KB